Peptide Receptor Radionuclide Therapy (PRRT)
One of the most significant treatment options for neuroendocrine cancer patients became available with the 2018 FDA approval of Lutathera®, the first radiopharmaceutical for Peptide Receptor Radionuclide Therapy (PRRT).
NET experts Dr. Emily Bergsland, Dr. Pamela Kunz, Dr. Erik Mittra and Dr.
Jonathan Strosberg describe the treatment, how it works, and the benefits for patients.
What do physicians look forward to in the future for PRRT?
Видео Peptide Receptor Radionuclide Therapy (PRRT) канала Carcinoid Cancer Foundation
NET experts Dr. Emily Bergsland, Dr. Pamela Kunz, Dr. Erik Mittra and Dr.
Jonathan Strosberg describe the treatment, how it works, and the benefits for patients.
What do physicians look forward to in the future for PRRT?
Видео Peptide Receptor Radionuclide Therapy (PRRT) канала Carcinoid Cancer Foundation
Показать
Комментарии отсутствуют
Информация о видео
21 августа 2020 г. 20:07:59
00:10:11
Другие видео канала
Who is a Good Candidate for PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD
What does a PRRT Day Look Like? (09 NETRF Chicago Pat Ed Conference)
Treatment Sequencing for NETs: Where Does PRRT Fit In? Chandrasekharan
PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD
Neuroendocrine Tumor Treatments with Richard RP Warner, MD
How PRRT Can Improve Care for Neuroendocrine Tumor Patients
Clinical Trials: Neuroendocrine Tumors
Peptide Receptor Radionuclide Therapy for NETs
Rare Disease Day Special 2017: Understanding Neuroendocrine Tumors
Cognitive Behavioral Therapy Exercises (FEEL Better!)
Basics of PRRT (08 NETRF Chicago Pat Ed Conference)
Neuroendocrine Tumor Treatment and Nutrition with Leigh Anne Burns, RDN
Nuclear medicine for NETs, Lisa Bodei, MD, Memorial Sloan Kettering
Why societies collapse | Jared Diamond
Improving PRRT for Neuroendocrine Tumors (NETs)
Play Therapy Works!
Dr. Philip Discusses the Use of Lutathera in NETs
Lutathera: New Treatment for Neuroendocrine Tumors at UVA
Symptoms and treatment of pancreatic neuroendocrine tumors (PNETs) - Mayo Clinic
Role of PRRT in the Management of NETs